MCID: VLV023
MIFTS: 18

Vulvar Eccrine Porocarcinoma

Categories: Cancer diseases, Reproductive diseases

Aliases & Classifications for Vulvar Eccrine Porocarcinoma

MalaCards integrated aliases for Vulvar Eccrine Porocarcinoma:

Name: Vulvar Eccrine Porocarcinoma 12 15 71

Classifications:



External Ids:

Disease Ontology 12 DOID:7565
NCIt 49 C40306
UMLS 71 C1520081

Summaries for Vulvar Eccrine Porocarcinoma

Disease Ontology : 12 A vulva carcinoma that is characterized by heterogenous histology that includes squamous cells, mucinous cells, clear cells, pigmented cells, and spindle cells and derives from eccrine sweat glands.

MalaCards based summary : Vulvar Eccrine Porocarcinoma is related to eccrine porocarcinoma and eccrine acrospiroma. An important gene associated with Vulvar Eccrine Porocarcinoma is PIP (Prolactin Induced Protein), and among its related pathways/superpathways is Cell adhesion_Cell-matrix glycoconjugates.

Related Diseases for Vulvar Eccrine Porocarcinoma

Diseases related to Vulvar Eccrine Porocarcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 303, show less)
# Related Disease Score Top Affiliating Genes
1 eccrine porocarcinoma 30.5 MUC1 CEACAM5
2 eccrine acrospiroma 30.4 PIP CEACAM5
3 bartholin's gland adenocarcinoma 10.3 PTGER4 PIP
4 peritoneal serous papillary adenocarcinoma 10.3 PTGER4 PIP
5 anal canal paget's disease 10.2 PIP CDKN2A
6 apocrine adenocarcinoma 10.2 PIP MUC1
7 sebaceous adenocarcinoma 10.2 PTGER4 PIP
8 syringocystadenoma papilliferum 10.2 PIP MUC1
9 lymphocytic colitis 10.2 PTGER4 CHGA
10 glycogen-rich clear cell breast carcinoma 10.2 SYP PIP
11 anal canal carcinoma 10.2 PIP CDKN2A
12 parachordoma 10.2 MUC1 CHGA
13 solid adenocarcinoma with mucin production 10.2 MUC1 CHGA
14 lobular neoplasia 10.1 PIP MUC1
15 epithelioid malignant peripheral nerve sheath tumor 10.1 MUC1 CHGA
16 malignant peritoneal mesothelioma 10.1 MUC1 CDKN2A
17 breast benign neoplasm 10.1 PIP MUC1
18 endometrial mucinous adenocarcinoma 10.1 MUC1 CDKN2A
19 subungual glomus tumor 10.1 SYP PIP
20 primary hepatic neuroendocrine carcinoma 10.1 SYP CHGA
21 plasmablastic lymphoma 10.1 MUC1 CDKN2A
22 small cell carcinoma of the bladder 10.1 SYP CHGA
23 acinar cell cystadenocarcinoma 10.1 SYP CHGA
24 cervical large cell neuroendocrine carcinoma 10.1 SYP CHGA
25 large cell neuroendocrine carcinoma 10.1 SYP CHGA
26 gastrointestinal neuroendocrine benign tumor 10.1 SYP CHGA
27 auditory system benign neoplasm 10.1 SYP CHGA
28 appendix carcinoid tumor 10.1 SYP CHGA
29 auditory system cancer 10.1 SYP CHGA
30 mixed ductal-endocrine carcinoma 10.1 SYP CHGA
31 cauda equina neoplasm 10.1 SYP CHGA
32 duodenal benign neoplasm 10.1 SYP CHGA
33 ampulla of vater neoplasm 10.1 SYP CHGA
34 urinary bladder small cell neuroendocrine carcinoma 10.1 SYP CHGA
35 ureter small cell carcinoma 10.1 SYP CHGA
36 breast papillary carcinoma 10.1 SYP CHGA
37 laryngeal neuroendocrine tumor 10.1 SYP CHGA
38 carotid body cancer 10.1 SYP CHGA
39 gallbladder small cell carcinoma 10.1 SYP CHGA
40 gastric neuroendocrine neoplasm 10.1 SYP CHGA
41 sensory organ benign neoplasm 10.1 SYP CHGA
42 subependymoma 10.1 SYP CHGA
43 pineocytoma 10.1 SYP CHGA
44 ovarian large-cell neuroendocrine carcinoma 10.1 SYP CHGA
45 gastric hemangioma 10.1 SYP CHGA
46 pancreatic gastrinoma 10.1 SYP CHGA
47 gastrinoma 10.1 SYP CHGA
48 lung oat cell carcinoma 10.1 SYP CHGA
49 cutaneous ganglioneuroma 10.1 SYP CHGA
50 ganglioneuroma 10.1 SYP CHGA
51 cervical neuroblastoma 10.1 SYP CHGA
52 cervix small cell carcinoma 10.1 SYP CHGA
53 bile duct adenoma 10.1 MUC1 CDKN2A
54 gastrointestinal neuroendocrine tumor 10.1 SYP CHGA
55 carcinoid tumors, intestinal 10.1 SYP CHGA
56 pulmonary large cell neuroendocrine carcinoma 10.1 SYP CHGA
57 vaginal adenoma 10.1 SYP CHGA
58 adenomyoma 10.1 MUC1 CDKN2A
59 cholangiolocellular carcinoma 10.1 MUC1 CDKN2A
60 carcinoid syndrome 10.1 SYP CHGA
61 binswanger's disease 10.1 SYP CHGA
62 endometrial small cell carcinoma 10.1 SYP CHGA
63 mammary paget's disease 10.1 PIP MUC1
64 pancreatic acinar cell adenocarcinoma 10.1 SYP CHGA
65 extracranial neuroblastoma 10.1 SYP CHGA
66 olfactory neuroblastoma 10.1 SYP CHGA
67 vaginal benign neoplasm 10.1 SYP CHGA
68 extra-adrenal pheochromocytoma 10.1 SYP CHGA
69 pulmonary neuroendocrine tumor 10.1 SYP CHGA
70 prostate neuroendocrine neoplasm 10.1 SYP CHGA
71 small intestine benign neoplasm 10.1 SYP CHGA
72 glomangiomatosis 10.1 SYP CHGA
73 olfactory nerve neoplasm 10.1 SYP CHGA
74 cranial nerve malignant neoplasm 10.1 SYP CHGA
75 sinonasal undifferentiated carcinoma 10.1 SYP MUC1
76 granulosa cell tumor of the ovary 10.1 SYP CHGA
77 papillary tumor of the pineal region 10.1 SYP MUC1
78 bile duct mucinous adenocarcinoma 10.1 SYP MUC1
79 horseshoe kidney 10.1 SYP CHGA
80 acral lentiginous melanoma 10.1 MUC1 CDKN2A
81 cranial nerve neoplasm 10.0 SYP CHGA
82 pleomorphic liposarcoma 10.0 MUC1 CDKN2A
83 cerebral primitive neuroectodermal tumor 10.0 SYP MUC1
84 sarcomatoid mesothelioma 10.0 MUC1 CDKN2A
85 adrenal medulla cancer 10.0 SYP CHGA
86 pulmonary sclerosing hemangioma 10.0 SYP CHGA
87 autonomic nervous system benign neoplasm 10.0 SYP CHGA
88 peripheral nervous system benign neoplasm 10.0 SYP CHGA
89 papillary squamous carcinoma 10.0 SYP CDKN2A
90 pancreatic endocrine carcinoma 10.0 SYP CHGA
91 extraskeletal ewing sarcoma 10.0 SYP MUC1
92 anaplastic ependymoma 10.0 SYP MUC1
93 anal paget's disease 10.0 PIP CEACAM5
94 eccrine papillary adenoma 10.0 PIP CEACAM5
95 vulvar syringoma 10.0 PIP CEACAM5
96 fox-fordyce disease 10.0 PIP CEACAM5
97 clear cell ependymoma 10.0 SYP MUC1
98 cutaneous mucoepidermoid carcinoma 10.0 PIP CEACAM5
99 vulva adenocarcinoma 10.0 PIP CEACAM5
100 vulval paget's disease 10.0 PIP CEACAM5
101 collecting duct carcinoma 10.0 MUC1 CDKN2A
102 eccrine adenocarcinoma 10.0 PIP CEACAM5
103 pleomorphic xanthoastrocytoma 10.0 SYP CHGA
104 vulvar apocrine adenocarcinoma 10.0 PIP CEACAM5
105 central neurocytoma 10.0 SYP CHGA
106 chordoid glioma 10.0 SYP MUC1
107 clear cell hidradenoma 10.0 PIP CEACAM5
108 hidrocystoma 10.0 PIP CEACAM5
109 ovarian small cell carcinoma 10.0 SYP MUC1
110 malignant epithelial mesothelioma 10.0 PTGER4 CEACAM5
111 retroperitoneum carcinoma 10.0 SYP CDKN2A
112 astroblastoma 10.0 SYP MUC1
113 myxopapillary ependymoma 10.0 SYP MUC1
114 eccrine sweat gland neoplasm 10.0 PIP CEACAM5
115 rhabdoid tumor predisposition syndrome 1 10.0 SYP MUC1
116 medulloepithelioma 10.0 SYP MUC1
117 cutaneous adenocystic carcinoma 10.0 PIP CEACAM5
118 apocrine sweat gland neoplasm 10.0 PIP CEACAM5
119 benign mesothelioma 10.0 PTGER4 CEACAM5
120 subependymal giant cell astrocytoma 10.0 SYP CHGA
121 pericardium cancer 10.0 PTGER4 CEACAM5
122 supratentorial cancer 10.0 SYP CDKN2A
123 papilloma of choroid plexus 10.0 SYP MUC1
124 lung large cell carcinoma 10.0 SYP CHGA
125 acinar cell carcinoma 10.0 SYP CHGA
126 gliomatosis cerebri 10.0 SYP CDKN2A
127 vaginal glandular tumor 10.0 CHGA CEACAM5
128 malignant pheochromocytoma 10.0 SYP CHGA
129 mesenchymal chondrosarcoma 10.0 SYP MUC1
130 pulmonary blastoma 9.9 SYP CHGA
131 sweat gland benign neoplasm 9.9 PIP CEACAM5
132 sertoli-leydig cell tumor 9.9 SYP MUC1
133 female urethral cancer 9.9 CHGA CEACAM5
134 adult teratoma 9.9 CHGA CEACAM5
135 squamous papillomatosis 9.9 PTGER4 CEACAM5
136 appendiceal neoplasm 9.9 CHGA CEACAM5
137 sertoli cell tumor 9.9 SYP MUC1
138 villous adenoma 9.9 MUC1 CEACAM5
139 hemangiopericytoma, malignant 9.9 SYP MUC1
140 well-differentiated liposarcoma 9.9 MUC1 CDKN2A
141 syringoma 9.9 MUC1 CEACAM5
142 central nervous system benign neoplasm 9.9 SYP CHGA
143 sweat gland disease 9.9 PIP CEACAM5
144 parotid gland adenoid cystic carcinoma 9.9 CEACAM5 CDKN2A
145 pancreatic foamy gland adenocarcinoma 9.9 MUC1 CEACAM5
146 urinary bladder villous adenoma 9.9 MUC1 CEACAM5
147 clear cell basal cell carcinoma 9.9 CHGA CEACAM5
148 lipid-rich breast carcinoma 9.9 MUC1 CEACAM5
149 mucinous intrahepatic cholangiocarcinoma 9.9 MUC1 CEACAM5
150 bile duct cystadenocarcinoma 9.9 MUC1 CEACAM5
151 adrenal cortical adenoma 9.9 SYP CHGA
152 biliary papillomatosis 9.9 MUC1 CEACAM5
153 colonic lymphangioma 9.9 MUC1 CEACAM5
154 bile duct mucoepidermoid carcinoma 9.9 MUC1 CEACAM5
155 benign ependymoma 9.9 SYP MUC1
156 chondroid chordoma 9.9 MUC1 CEACAM5
157 biliary tract benign neoplasm 9.9 MUC1 CEACAM5
158 pancreatic mucinous cystadenoma 9.9 MUC1 CEACAM5
159 cystic basal cell carcinoma 9.9 SYP PTGER4 PIP
160 rectum adenocarcinoma 9.9 PIP CEACAM5
161 epithelioid sarcoma 9.9 SYP MUC1
162 appendix disease 9.9 MUC1 CEACAM5
163 keratinizing squamous cell carcinoma 9.9 CEACAM5 CDKN2A
164 islet cell tumor 9.9 SYP CHGA
165 pre-malignant neoplasm 9.9 PIP MUC1 CDKN2A
166 in situ carcinoma 9.9 PIP MUC1 CDKN2A
167 secretory meningioma 9.9 MUC1 CEACAM5
168 appendix cancer 9.9 MUC1 CEACAM5
169 ovarian benign neoplasm 9.8 MUC1 CEACAM5
170 breast neuroendocrine neoplasm 9.8 SYP PIP CHGA
171 ductal carcinoma in situ 9.8 PIP MUC1 CDKN2A
172 hepatoid adenocarcinoma 9.8 MUC1 CEACAM5
173 papillary adenoma 9.8 SYP CEACAM5
174 thyroid gland medullary carcinoma 9.8 CHGA CEACAM5
175 mucinous adenofibroma 9.8 SYP CEACAM5
176 duodenum cancer 9.8 MUC1 CEACAM5
177 endodermal sinus tumor 9.8 CHGA CEACAM5
178 vulva basal cell carcinoma 9.8 SYP CEACAM5
179 duodenum disease 9.8 MUC1 CEACAM5
180 mucinous cystadenocarcinoma 9.8 MUC1 CEACAM5
181 giant cell glioblastoma 9.8 SYP CDKN2A
182 adrenal gland disease 9.8 SYP CHGA
183 myoblastoma 9.8 SYP CEACAM5
184 endocervical carcinoma 9.8 CEACAM5 CDKN2A
185 dry eye syndrome 9.8 PIP MUC1
186 pancreatic ductal carcinoma 9.8 MUC1 CDKN2A
187 pseudomyxoma peritonei 9.8 MUC1 CEACAM5
188 primary pigmented nodular adrenocortical disease 9.8 SYP CHGA
189 cavernous hemangioma 9.8 SYP MUC1
190 nasal cavity olfactory neuroblastoma 9.8 SYP CEACAM5
191 adenocarcinoma in situ 9.8 CEACAM5 CDKN2A
192 sex cord-gonadal stromal tumor 9.8 MUC1 CEACAM5
193 cholecystitis 9.8 MUC1 CDKN2A
194 keratosis, seborrheic 9.8 CEACAM5 CDKN2A
195 ovarian germ cell cancer 9.8 SYP CEACAM5
196 polycystic liver disease 1 with or without kidney cysts 9.8 MUC1 CEACAM5
197 malignant teratoma 9.8 SYP CEACAM5
198 breast ductal carcinoma 9.8 SYP PIP MUC1
199 mature teratoma 9.7 SYP CEACAM5
200 breast adenocarcinoma 9.7 SYP PIP CHGA
201 tonsil cancer 9.7 CEACAM5 CDKN2A
202 esophageal neuroendocrine tumor 9.7 SYP MUC1 CHGA
203 middle ear adenoma 9.7 SYP MUC1 CHGA
204 laryngeal small cell carcinoma 9.7 SYP CHGA CDKN2A
205 pineoblastoma 9.7 SYP CEACAM5
206 chordoid meningioma 9.7 SYP MUC1 CHGA
207 reproductive organ benign neoplasm 9.7 CEACAM5 CDKN2A
208 malignant syringoma 9.7 PTGER4 PIP CEACAM5
209 clear cell meningioma 9.7 SYP MUC1 CHGA
210 microcystic adenoma 9.7 SYP MUC1 CHGA
211 eccrine sweat gland cancer 9.7 PTGER4 PIP CEACAM5
212 sclerosing hemangioma 9.7 SYP MUC1 CHGA
213 hemangioma 9.7 SYP MUC1 CHGA
214 pancreatoblastoma 9.7 SYP MUC1 CHGA
215 myxoid chondrosarcoma 9.7 SYP MUC1 CHGA
216 anus disease 9.7 CEACAM5 CDKN2A
217 basaloid squamous cell carcinoma 9.7 SYP CHGA CDKN2A
218 respiratory system benign neoplasm 9.7 SYP CHGA CDKN2A
219 adrenal cortical carcinoma 9.7 SYP MUC1 CHGA
220 spindle cell carcinoma 9.7 SYP MUC1 CHGA
221 atypical teratoid rhabdoid tumor 9.7 SYP MUC1 CHGA
222 lung benign neoplasm 9.7 SYP CHGA CDKN2A
223 rectal disease 9.7 CEACAM5 CDKN2A
224 papillary carcinoma 9.7 SYP MUC1 CHGA
225 pleural cancer 9.7 CEACAM5 CDKN2A
226 ewing sarcoma 9.7 SYP CHGA CDKN2A
227 gastrointestinal carcinoma 9.7 MUC1 CEACAM5
228 perivascular epithelioid cell tumor 9.7 SYP MUC1 CDKN2A
229 glomus tumor 9.7 SYP MUC1 CDKN2A
230 choroid plexus cancer 9.7 SYP CEACAM5
231 neurofibroma 9.7 SYP MUC1 CDKN2A
232 suppression of tumorigenicity 12 9.7 SYP CHGA CDKN2A
233 oligodendroglioma 9.7 SYP CHGA CDKN2A
234 nodular hidradenoma 9.6 PIP MUC1 CEACAM5
235 hidradenoma 9.6 PIP MUC1 CEACAM5
236 linitis plastica 9.6 PIP MUC1 CEACAM5
237 papillary adenocarcinoma 9.6 PIP MUC1 CEACAM5
238 gastric diffuse adenocarcinoma 9.6 PIP MUC1 CEACAM5
239 paget disease, extramammary 9.6 PIP MUC1 CEACAM5
240 borst-jadassohn intraepidermal carcinoma 9.6 PIP CEACAM5 CDKN2A
241 vulvar disease 9.6 PIP CEACAM5 CDKN2A
242 thoracic benign neoplasm 9.6 PIP MUC1 CEACAM5
243 small intestine cancer 9.6 MUC1 CEACAM5
244 vulva cancer 9.6 PIP CEACAM5 CDKN2A
245 thymoma 9.6 SYP MUC1 CDKN2A
246 lymphohistiocytoid mesothelioma 9.6 PTGER4 CEACAM5 CDKN2A
247 benign peritoneal mesothelioma 9.6 PTGER4 MUC1 CEACAM5
248 peritoneum cancer 9.6 PTGER4 CEACAM5 CDKN2A
249 gastrointestinal stromal tumor 9.6 SYP CHGA CDKN2A
250 sweat gland cancer 9.6 SYP PIP CEACAM5
251 eccrine papillary adenocarcinoma 9.6 SYP PIP CEACAM5
252 peritoneal serous adenocarcinoma 9.5 SYP PTGER4 PIP CHGA
253 tumor of exocrine pancreas 9.5 MUC1 CEACAM5 CDKN2A
254 peritoneal mesothelioma 9.5 MUC1 CEACAM5 CDKN2A
255 endocervical adenocarcinoma 9.5 MUC1 CEACAM5 CDKN2A
256 ovarian cystadenocarcinoma 9.5 MUC1 CEACAM5 CDKN2A
257 mucinous adenocarcinoma 9.5 MUC1 CEACAM5 CDKN2A
258 carcinosarcoma 9.5 MUC1 CEACAM5 CDKN2A
259 ampulla of vater cancer 9.5 MUC1 CEACAM5
260 ovary adenocarcinoma 9.5 MUC1 CEACAM5 CDKN2A
261 pancreatic serous cystadenocarcinoma 9.5 SYP CHGA CEACAM5
262 gastric small cell carcinoma 9.5 SYP CHGA CEACAM5
263 esophageal adenoid cystic carcinoma 9.5 SYP CHGA CEACAM5
264 appendix adenocarcinoma 9.5 SYP CHGA CEACAM5
265 ovary epithelial cancer 9.5 MUC1 CEACAM5 CDKN2A
266 malignant ovarian surface epithelial-stromal neoplasm 9.5 MUC1 CEACAM5 CDKN2A
267 colon neuroendocrine neoplasm 9.5 SYP CHGA CEACAM5
268 mediastinal cancer 9.5 SYP CHGA CEACAM5
269 cecal disease 9.5 SYP CHGA CEACAM5
270 mixed cell type cancer 9.5 SYP CHGA CEACAM5
271 pancreatic cystadenoma 9.5 SYP CHGA CEACAM5
272 cardiovascular organ benign neoplasm 9.5 SYP CHGA CEACAM5
273 mesothelioma, malignant 9.5 MUC1 CEACAM5 CDKN2A
274 krukenberg carcinoma 9.5 SYP MUC1 CEACAM5
275 basal cell carcinoma 9.4 SYP CEACAM5 CDKN2A
276 bile duct cancer 9.4 MUC1 CEACAM5 CDKN2A
277 cystic teratoma 9.4 SYP CEACAM5 CDKN2A
278 thymic carcinoma 9.4 SYP MUC1 CEACAM5
279 gallbladder cancer 9.4 MUC1 CEACAM5 CDKN2A
280 actinic keratosis 9.4 CEACAM5 CDKN2A
281 adenoma 9.3 SYP MUC1 CHGA CDKN2A
282 small cell carcinoma 9.3 SYP MUC1 CHGA CDKN2A
283 merkel cell carcinoma 9.3 SYP MUC1 CHGA CDKN2A
284 malignant spiradenoma 9.3 PTGER4 PIP CEACAM5 CDKN2A
285 thyroid gland cancer 9.3 SYP CHGA CEACAM5
286 signet ring cell adenocarcinoma 9.3 PIP MUC1 CHGA CEACAM5
287 thyroid carcinoma, familial medullary 9.3 CHGA CEACAM5
288 papillary thymic adenocarcinoma 9.2 SYP PTGER4 CHGA CEACAM5
289 mucoepidermoid carcinoma 9.2 MUC1 CHGA CEACAM5 CDKN2A
290 colorectal adenocarcinoma 9.2 MUC1 CHGA CEACAM5 CDKN2A
291 lung cancer susceptibility 3 9.2 PIP MUC1 CEACAM5 CDKN2A
292 gastric adenocarcinoma 9.1 MUC1 CHGA CEACAM5 CDKN2A
293 vaginal tubulovillous adenoma 9.1 SYP CHGA CEACAM5 CDKN2A
294 tubular adenocarcinoma 9.1 SYP MUC1 CHGA CEACAM5
295 benign teratoma 9.1 SYP MUC1 CHGA CEACAM5
296 cystadenoma 9.1 SYP MUC1 CHGA CEACAM5
297 teratoma 9.1 SYP CHGA CEACAM5 CDKN2A
298 adenosquamous carcinoma 9.1 SYP MUC1 CHGA CEACAM5
299 large cell carcinoma 9.1 SYP MUC1 CHGA CEACAM5
300 neuroendocrine carcinoma 9.1 SYP MUC1 CHGA CEACAM5
301 small cell cancer of the lung 9.1 SYP CHGA CEACAM5 CDKN2A
302 cell type benign neoplasm 9.1 SYP CHGA CEACAM5 CDKN2A
303 ovarian serous cystadenocarcinoma 9.1 SYP MUC1 CEACAM5 CDKN2A

Graphical network of the top 20 diseases related to Vulvar Eccrine Porocarcinoma:



Diseases related to Vulvar Eccrine Porocarcinoma

Symptoms & Phenotypes for Vulvar Eccrine Porocarcinoma

Drugs & Therapeutics for Vulvar Eccrine Porocarcinoma

Search Clinical Trials , NIH Clinical Center for Vulvar Eccrine Porocarcinoma

Genetic Tests for Vulvar Eccrine Porocarcinoma

Anatomical Context for Vulvar Eccrine Porocarcinoma

Publications for Vulvar Eccrine Porocarcinoma

Articles related to Vulvar Eccrine Porocarcinoma:

(showing 3, show less)
# Title Authors PMID Year
1
Vulvar eccrine porocarcinoma: report of a case and literature review. 61
29556664 2017
2
Eccrine porocarcinoma of the vulva: a case report and review of the literature. 61
27832810 2016
3
Vulvar eccrine porocarcinoma. 61
8812539 1996

Variations for Vulvar Eccrine Porocarcinoma

Expression for Vulvar Eccrine Porocarcinoma

Search GEO for disease gene expression data for Vulvar Eccrine Porocarcinoma.

Pathways for Vulvar Eccrine Porocarcinoma

Pathways related to Vulvar Eccrine Porocarcinoma according to GeneCards Suite gene sharing:

(showing 1, show less)
# Super pathways Score Top Affiliating Genes
1 10.21 MUC1 CEACAM5

GO Terms for Vulvar Eccrine Porocarcinoma

Sources for Vulvar Eccrine Porocarcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....